Internal Medicine · Muscle Shoals, AL
NPI
1033436191
Since 2010
Specialty
Internal Medicine
Code 207R00000X
Group practices
5
Medicare group memberships
Hospitals
4
Hospital affiliations
102 Physicians Dr Ste A
Muscle Shoals, AL, 35661
Phone (256) 286-4026
Groups this clinician bills Medicare through
Medicare paid, 2024
$233K
9,637 services
Medicare patients, 2024
353
Average age 71
Drug cost, 2024
$1.9M
17,921 prescriptions
Company payments, 2025
$1,561
From 22 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Roy Barco was code 99490 (chronic, principal, and transitional care management), 1,781 times for 192 patients. In total Roy Barco billed 9,637 services in 90 codes, and Medicare paid $233K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-09-05.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99490 Chronic, Principal, and Transitional Care Management | Office | 1,781 | 192 | $41.26 | $73K |
| 99214 Office E&M - Established | Office | 803 | 251 | $74.36 | $60K |
| 36415 Venipuncture Blood Collection | Office | 428 | 201 | $8.57 | $3,669 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 407 | 189 | $10.27 | $4,182 |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 380 | 45 | $0.08 | $30.63 |
| 96372 Injection Administration | Office | 266 | 74 | $8.03 | $2,135 |
| 99457 E&M - Miscellaneous | Office | 186 | 30 | $32.66 | $6,075 |
| G0444 Annual depression screening, 5 to 15 minutes | Office | 173 | 173 | $16.44 | $2,845 |
| G0442 Annual alcohol misuse screening, 5 to 15 minutes | Office | 167 | 167 | $16.46 | $2,748 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 164 | 164 | $114.41 | $19K |
| J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 150 | 33 | $0.79 | $118 |
| J0696 Injection, ceftriaxone sodium, per 250 mg | Office | 142 | 30 | $0.30 | $43.06 |
| G0446 Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes | Office | 139 | 139 | $22.65 | $3,148 |
| 99213 Office E&M - Established | Office | 133 | 118 | $58.46 | $7,775 |
| 99454 E&M - Miscellaneous | Office | 127 | 24 | $29.87 | $3,793 |
By year: 2022 $217K for 16,793 services; 2023 $249K for 13,994 services; 2024 $233K for 9,637 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 428 | 201 | $8.57 | $3,669 |
| 80305 Drug Tests | 72 | 23 | $12.04 | $867 |
| 81002 Clinical Chemistry | 38 | 35 | $3.33 | $127 |
| 87426 Immunoassay | 19 | 16 | $34.62 | $658 |
| 87804 Immunoassay | 14 | 12 | $16.22 | $227 |
Medicare prescription drug claims, 2024
In 2024, the drug Roy Barco prescribed most often to Medicare patients was Gabapentin, with 828 prescriptions and refills. In total Roy Barco wrote 17,921 Medicare prescriptions that cost $1.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gabapentin Generic | 828 | 1,011 | 166 | $11K |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 571 | 571 | 85 | $11K |
| Pregabalin Generic | 550 | 560 | 106 | $8,787 |
| Buprenorphine-Naloxone Buprenorphine Hcl/Naloxone Hcl | 535 | 535 | 66 | $118K |
| Amlodipine Besylate Generic | 485 | 1,008 | 139 | $2,332 |
| Levothyroxine Sodium Generic | 436 | 920 | 131 | $3,338 |
| Clonazepam Generic | 429 | 455 | 64 | $2,064 |
| Pantoprazole Sodium Generic | 427 | 831 | 127 | $4,701 |
| Rosuvastatin Calcium Generic | 423 | 1,015 | 141 | $5,363 |
| Atorvastatin Calcium Generic | 411 | 1,022 | 146 | $4,063 |
| Omeprazole Generic | 371 | 831 | 121 | $4,980 |
| Lisinopril Generic | 365 | 821 | 119 | $2,186 |
| Tramadol Hcl Generic | 364 | 376 | 84 | $3,394 |
| Montelukast Sodium Generic | 341 | 684 | 97 | $3,596 |
| Metformin Hcl Generic | 281 | 665 | 109 | $1,499 |
Brand drugs: 1,859 claims; generic drugs: 15,991 claims; opioid claims: 1,036.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Roy Barco $1,561 ($1,561 in general payments such as food, travel and fees) from 22 companies. The largest payer was Abbvie Inc. with $279.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 27 | $279 |
| AstraZeneca Pharmaceuticals LP AZN | 8 | $182 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 9 | $174 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 5 | $112 |
| Indivior Inc. INDV | 3 | $91.85 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 4 | $81.01 |
| Vanda Pharmaceuticals Inc. VNDA | 2 | $59.98 |
| Pfizer Inc. PFE | 4 | $58.81 |
| Axsome Therapeutics, Inc. AXSM | 3 | $57.3 |
| Exact Sciences Corporation EXAS | 3 | $55.12 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.